Pacer Advisors
TWST icon

Pacer Advisors’s Twist Bioscience TWST Stock Holding History

Pacer Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-586
Closed -$28.9K – 2700
2024
Q2 		$28.9K Sell
586
-552
-49% -$22.5K ﹤0.01% 3352
2024
Q1 		$39K Buy
+1,138
New +$41.1K ﹤0.01% 3269
2021
Q2 		– Sell
-546
Closed -$68K – 1557
2021
Q1 		$68K Sell
546
-382
-41% -$58K ﹤0.01% 1391
2020
Q4 		$131K Sell
928
-1,012
-52% -$112K ﹤0.01% 1316
2020
Q3 		$147K Buy
+1,940
New +$121K ﹤0.01% 1213

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pacer Advisors's TWST Position: Q3 2024 in Review

Pacer Advisors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 586 shares — an estimated $28.9K sold.

Pacer Advisors first reported a position in TWST in Q3 2020 and held it in 5 quarters. The position peaked at $147K in Q3 2020. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Pacer Advisors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 586 Twist Bioscience shares in Q3 2024, an estimated $28.9K.
  • Pacer Advisors first reported a position in Twist Bioscience in Q3 2020 and held it in 5 quarters.
  • Pacer Advisors's Twist Bioscience position peaked at $147K in Q3 2020.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.